SOLSTICE BIOLOGICS LLC

Profile

Company Names

SOLSTICE BIOLOGICS LLC

Addresses

1700 OWENS STREET, SUITE 595, SAN FRANCISCO, CA 94158

Phone Numbers

415-800-0800

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$22,000,000.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2015-12-15 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
3
2014-09-23 
$7,500,000.00 
$7,500,000.00 
$0.00 
Equity 
2
2012-12-19 
$7,500,000.00 
$7,500,000.00 
$0.00 
Equity 
1
2012-11-29 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ADELMAN 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SIENTRA, INC.   |  ARAGON PHARMACEUTICALS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  PRECISION BIOSCIENCES INC   |  METACRINE, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  TP THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.
JOHN 
 
BORGESON 
EXECUTIVE OFFICER
ARIDIS PHARMACEUTICALS, INC.   |  SOLSTICE BIOLOGICS LLC   |  KODIAK SCIENCES INC.
CURT 
 
BRADSHAW 
DIRECTOR, EXECUTIVE OFFICER, PROMOTER
SOLSTICE BIOLOGICS LLC
STEVEN 
 
DOWDY 
DIRECTOR
SOLSTICE BIOLOGICS LLC
COREY 
 
GOODMAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
LIMERICK BIOPHARMA INC   |  IPIERIAN, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SECOND GENOME, INC.   |  MIRNA THERAPEUTICS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  ALEXO THERAPEUTICS LTD   |  CHECKMATE PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  NFLECTION THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  TALLAC THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.   |  ATTRALUS, INC.   |  INSAMO INC.   |  VENBIO GLOBAL STRATEGIC FUND V, L.P.
FRANK 
 
MUHLENBECK 
DIRECTOR
CONFORMIS INC   |  SOLSTICE BIOLOGICS LLC   |  AMPHIVENA THERAPEUTICS, INC.   |  GENOMEDX INC.   |  DECIPHER BIOSCIENCES, INC.
GEORGE 
 
REHM 
DIRECTOR
CRESCENDO BIOSCIENCE, INC.   |  JIFF, INC.   |  SOLSTICE BIOLOGICS LLC   |  GENOMEDX BIOSCIENCES INC.   |  EMPOWER HEALTH EQUITY, INC.   |  INKSPACE IMAGING, INC.
LOUIS 
 
TARTAGLIA 
DIRECTOR
ZAFGEN, INC.   |  EMBER THERAPEUTICS, INC.   |  SOLSTICE BIOLOGICS LLC   |  CYCLOPORTERS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  CURE VENTURES FUND I, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-12-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-15 
2014-10-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-23 
2012-12-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-19 
2012-12-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#